Stemline Therapeutics Inc (NASDAQ:STML)

16.06
BATS BZX Real-Time Price
As of 10:23am ET
 +0.01 / +0.06%
Today’s Change
10.50
Today|||52-Week Range
27.12
-5.86%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues0.000.000.0071.0K
 
 
Depreciation And Amortization0.000.00--76.7K
 
 
 
Operating ExpensesGross Income0.000.000.00----
General Expenses2.3M2.7M6.5M24.0M
 
 
 
 
 
Research And Development1.3M1.6M3.4M16.2M
 
 
 
 
 
Total Operating Expenses2.3M2.7M6.5M24.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.3M-2.7M-6.5M-24.0M
 
 
 
 
 
Extraordinary Credit21.9K0.000.0030.4K
 
 
 
Extraordinary Charge0.00-9.7K0.000.00
 
 
Interest Expense On Debt69.5K98.6K118.8K516.9K
 
 
 
 
 
Other Expenses463.0K46.7K301.6K250.3K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.8M-2.8M-6.3M-24.2M
 
 
 
 
 
Net Income-1.8M-2.8M-6.3M-24.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS7.0M7.0M7.5M10.3M
 
 
 
 
 
Shares To Calculate EPS Diluted7.0M7.0M7.5M10.3M
 
 
 
 
 
 
Earnings Per ShareEPS$2.81-$0.80-$1.82-$2.35
 
 
 
 
 
EPS Diluted-$0.26-$0.40-$0.84-$2.35
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account